Challenges and opportunities of allogeneic donor-derived CAR T cells

Challenges and opportunities of allogeneic donor-derived CAR T cells

Item
http://www.wikidata.org/entity/Q36257036
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).The Flipside of the Power of Engineered T Cells: Observed and Potential Toxicities of Genetically Modified T Cells as Therapy.Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don't Forget the FuelSynthetic Immunology: Hacking Immune Cells to Expand Their Therapeutic Capabilities.Towards 'off-the-shelf' genetically modified T cells: prolonging functional engraftment in mice by CD8 veto T cells.Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells.Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled?Ribosome display and selection of single-chain variable fragments effectively inhibit growth and progression of microspheres in vitro and in vivo.Frontiers and Opportunities: Highlights of the 2 Annual Conference of the Chinese Antibody Society
P2860

Challenges and opportunities of allogeneic donor-derived CAR T cells

Item
http://www.wikidata.org/entity/Q36257036
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Challenges and opportunities of allogeneic donor-derived CAR T cells
@ast
Challenges and opportunities of allogeneic donor-derived CAR T cells
@en
type
label
Challenges and opportunities of allogeneic donor-derived CAR T cells
@ast
Challenges and opportunities of allogeneic donor-derived CAR T cells
@en
prefLabel
Challenges and opportunities of allogeneic donor-derived CAR T cells
@ast
Challenges and opportunities of allogeneic donor-derived CAR T cells
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Challenges and opportunities of allogeneic donor-derived CAR T cells
@en
P2093
P2860
P304
P31
P356
10.1097/MOH.0000000000000181
P433
P478
P577
P698
P932